tirzepatide fda approval date Grants a New Indication for Obesity Management Lilly's new drug Mounjaro (tirzepatide
Description
There is a boxed warning for Ozempic and Trulicity, which is the most serious warning required by the FDA
Side Effects & Considerations Most side effects are mild to moderate and relate to gastrointestinal effects during dose escalation, including nausea, diarrhea, constipation, which often improve over time
The people who climb slowly almost always report fewer side effects than those who chase faster results by skipping dose levels
Retatrutide is not designed to replace Metformin, though it offers powerful blood sugar control alongside its weight loss benefits
